Financial results - URO - ONCO MED S.R.L.

Financial Summary - Uro - Onco Med S.r.l.
Unique identification code: 40580144
Registration number: J05/537/2019
Nace: 8622
Sales - Ron
31.856
Net Profit - Ron
23.596
Employee
1
The most important financial indicators for the company Uro - Onco Med S.r.l. - Unique Identification Number 40580144: sales in 2023 was 31.856 euro, registering a net profit of 23.596 euro and having an average number of 1 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Uro - Onco Med S.r.l.

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR - - - - - 6.915 2.358 22.798 23.268 31.856
Total Income - EUR - - - - - 6.915 2.358 22.798 24.130 32.954
Total Expenses - EUR - - - - - 0 88 1.135 1.121 9.039
Gross Profit/Loss - EUR - - - - - 6.915 2.269 21.664 23.009 23.915
Net Profit/Loss - EUR - - - - - 6.708 2.199 20.980 22.445 23.596
Employees - - - - - 0 0 0 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 37.3%, from 23.268 euro in the year 2022, to 31.856 euro in 2023. The Net Profit increased by 1.219 euro, from 22.445 euro in 2022, to 23.596 in the last year.

Check the financial reports for the company - Uro - Onco Med S.r.l.

Rating financiar

Financial Rating -
Uro - Onco Med S.r.l.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Uro - Onco Med S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Uro - Onco Med S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Uro - Onco Med S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Uro - Onco Med S.r.l. - CUI 40580144

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets - - - - - 0 0 0 1.727 433
Current Assets - - - - - 6.957 8.841 11.378 26.524 42.928
Inventories - - - - - 0 0 0 0 0
Receivables - - - - - 6.915 6.784 8.819 24.349 36.079
Cash - - - - - 42 2.056 2.558 2.175 6.848
Shareholders Funds - - - - - 6.750 8.829 9.873 22.494 32.211
Social Capital - - - - - 42 41 40 41 40
Debts - - - - - 207 12 1.505 5.758 11.150
Income in Advance - - - - - 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 42.928 euro in 2023 which includes Inventories of 0 euro, Receivables of 36.079 euro and cash availability of 6.848 euro.
The company's Equity was valued at 32.211 euro, while total Liabilities amounted to 11.150 euro. Equity increased by 9.786 euro, from 22.494 euro in 2022, to 32.211 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Uro - Onco Med S.r.l.

Comments - Uro - Onco Med S.r.l.

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.